Unknown

Dataset Information

0

Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.


ABSTRACT: Noninvasive mucosal vaccines are attractive alternatives to parenteral vaccines. Although the conjugation of vaccine antigens with the B subunit of cholera toxin (CTB) is one of the most promising strategies for vaccine delivery to mucosal immune systems, the molecule cannot tolerate large-protein fusion, as it severely impairs pentamerization and loses affinity for GM1-ganglioside. Here we report a new strategy, in which steric hindrance between CTB-antigen fusion subunits is significantly reduced through the integration of unfused CTB "molecular buffers" into the pentamer unit, making them more efficiently self-assemble into biologically active pentamers. In addition, the chimeric protein took a compact configuration, becoming small enough to be secreted, and one-step affinity-purified proteins, when administered through a mucosal route, induced specific immune responses in mice. Since our results are not dependent on the use of a particular expression system or vaccine antigen, this strategy could be broadly applicable to bacterial enterotoxin-based vaccine design.

SUBMITTER: Harakuni T 

PROVIDER: S-EPMC1231140 | biostudies-literature | 2005 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.

Harakuni Tetsuya T   Sugawa Hideki H   Komesu Ai A   Tadano Masayuki M   Arakawa Takeshi T  

Infection and immunity 20050901 9


Noninvasive mucosal vaccines are attractive alternatives to parenteral vaccines. Although the conjugation of vaccine antigens with the B subunit of cholera toxin (CTB) is one of the most promising strategies for vaccine delivery to mucosal immune systems, the molecule cannot tolerate large-protein fusion, as it severely impairs pentamerization and loses affinity for GM1-ganglioside. Here we report a new strategy, in which steric hindrance between CTB-antigen fusion subunits is significantly redu  ...[more]

Similar Datasets

| S-EPMC6593289 | biostudies-literature
| S-EPMC7350353 | biostudies-literature
| S-EPMC9262165 | biostudies-literature
| S-EPMC440597 | biostudies-literature
| S-EPMC6963464 | biostudies-literature
| S-EPMC2890829 | biostudies-literature
| S-EPMC3603891 | biostudies-literature
| S-EPMC4860092 | biostudies-literature
| S-EPMC4589288 | biostudies-literature
| S-EPMC6581581 | biostudies-literature